The Economics of Cardiogenic Shock Programs: Show Me the Money

Management of cardiogenic shock requires a highly coordinated, multidisciplinary approach available 24 hours a day and is inherently resource-intensive. These demands often deter healthcare systems from investing in formal cardiogenic shock programs or establishing dedicated shock teams. However, when thoughtfully designed and executed, high-volume cardiogenic shock programs can be both clinically impactful and financially sustainable.

This symposium will focus on the economic considerations involved in establishing and maintaining a successful cardiogenic shock program. Topics will include the financial implications of temporary mechanical circulatory support device utilization, extracorporeal membrane oxygenation (ECMO), and the broader “halo effect” of a shock program on hospital revenue, reputation, and downstream service lines. The session will also address key expectations and requirements from hospital leadership and the C-suite to ensure long-term program success.

Learning Objectives

• Identify strategies to effectively communicate the value of a cardiogenic shock program to hospital leadership, aligning clinical goals with institutional priorities.
• Review the reimbursement landscape and potential financial benefits of a comprehensive cardiogenic shock program.
• Understand the necessary personnel, technological, and operational infrastructure requirements for a successful cardiogenic shock program.